Financial news
The newsroom
Headlines from the Federal Reserve, ECB, Bank of Japan, Bank of England, SEC EDGAR, the White House and the DOJ. Context notes are neutral and information-only, Kresmion publishes no buy or sell recommendations.
Public RSS feeds · refreshed every 30 minutes
7888 items from SEC EDGAR · clear filters
- 8-K - Ultragenyx Pharmaceutical Inc. (0001515673) (Filer)
Ultragenyx Pharmaceutical Inc. filed a Form 8-K on October 14, 2026 (Accession No. 0001193125-26-421079) reporting entry into a material definitive agreement.
- 8-K - SKYX Platforms Corp. (0001598981) (Filer)
SKYX Platforms Corp filed a Form 8-K reporting a material definitive agreement, completion of an acquisition, creation of a direct financial obligation, unregistered sales of equity securities, and related financial statements and exhibits.
- 8-K - Nordicus Partners Corp (0001011060) (Filer)
Nordicus Partners Corp filed a Form 8-K reporting entry into a material definitive agreement, the creation of a direct financial obligation or off-balance-sheet arrangement, and the inclusion of financial statements and related exhibits.
- 8-K - Aptevo Therapeutics Inc. (0001671584) (Filer)
Aptevo Therapeutics filed a Form 8-K on October 14, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - Integer Holdings Corp (0001114483) (Filer)
Integer Holdings Corp filed a Form 8-K under Item 8.01 (Other Events) with the SEC on October 14, 2026 (Accession No. 0000950103-26-015548).
- 8-K - Evolution Metals & Technologies Corp. (0001866226) (Filer)
Evolution Metals & Technologies Corp. filed a Form 8-K on October 14, 2026, containing a Regulation FD disclosure and the company’s financial statements and related exhibits.
- 8-K - PULSE BIOSCIENCES, INC. (0001625101) (Filer)
Pulse Biosciences, Inc. filed a Form 8-K on October 14, 2026, containing Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - Eagle Point Credit Co (0001604174) (Filer)
Eagle Point Credit Co. filed a Form 8-K reporting an Item 8.01 “Other Events” on October 14, 2026.
- 8-K - Data443 Risk Mitigation, Inc. (0001068689) (Filer)
Data443 Risk Mitigation, Inc. filed a Form 8-K with the SEC on October 14, 2026, including a Regulation FD disclosure (Item 7.01) and accompanying financial statements and exhibits (Item 9.01).
- 8-K - Vir Biotechnology, Inc. (0001706431) (Filer)
Vir Biotechnology filed a Form 8-K reporting unregistered sales of equity securities, other events, and accompanying financial statements and exhibits.
- 8-K - Datacentrex, Inc. (0001853825) (Filer)
Datacentrex, Inc. filed a Form 8-K on October 14, 2026, reporting other events under Item 8.01 and providing financial statements and related exhibits under Item 9.01.
- 8-K - Eagle Point Income Co (0001754836) (Filer)
Eagle Point Income Co filed a Form 8-K with the SEC on October 14, 2026, reporting an Item 8.01 “Other Events” disclosure.
- 8-K - Coya Therapeutics, Inc. (0001835022) (Filer)
Coya Therapeutics, Inc. filed a Form 8-K with the SEC on October 14, 2026, under Item 8.01 (Other Events), accession number 0001193125-26-421066, comprising a 148 KB document.
- 8-K - Valion Bio, Inc. (0001787740) (Filer)
Valion Bio, Inc. filed a Form 8-K on October 14, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - FLEX LTD. (0000866374) (Filer)
Flex Ltd. filed a Form 8-K reporting entry into a material definitive agreement, completion of an acquisition or asset disposition, creation of a direct financial obligation, other events, and accompanying financial statements and exhibits.
- 8-K - MAXCYTE, INC. (0001287098) (Filer)
MaxCyte, Inc. filed a Form 8-K on October 14, 2026, reporting its results of operations and financial condition under Item 2.02, and providing financial statements and related exhibits under Item 9.01.
- 8-K - Sabre Corp (0001597033) (Filer)
Sabre Corp filed a Form 8-K on October 14, 2026, reporting the termination of a material definitive agreement and providing information under Item 8.01 regarding other events.
- 8-K - Profound Medical Corp. (0001628808) (Filer)
Profound Medical Corp. filed a Form 8-K on October 14, 2026, containing a Regulation FD disclosure (Item 7.01) and accompanying financial statements and exhibits (Item 9.01).
- 8-K - WhiteHorse Finance, Inc. (0001552198) (Filer)
WhiteHorse Finance, Inc. filed a Form 8-K on October 14, 2026, containing a Regulation FD disclosure and accompanying financial statements and exhibits.
- 8-K - OneMedNet Corp (0001849380) (Filer)
OneMedNet Corp filed a Form 8-K with the SEC on October 14, 2026, reporting an Item 8.01 Other Events disclosure (Accession No. 0001493152-26-046931, 253 KB).
- 8-K - Fermi Inc. (0002071778) (Filer)
Fermi Inc. filed a Form 8-K on October 14, 2026, including a Regulation FD disclosure and accompanying financial statements and exhibits, under accession number 0001213900-26-109227.
- 8-K - Strive, Inc. (0001920406) (Filer)
Strive, Inc. filed a Form 8-K under Item 8.01 (Other Events) with the SEC on October 14, 2026, accession number 0001628280-26-065816.
- 8-K - Akebia Therapeutics, Inc. (0001517022) (Filer)
Akebia Therapeutics, Inc. filed a Form 8-K reporting the departure of certain directors or officers and the appointment of new officers, along with disclosed compensatory arrangements for the affected officers.
- 8-K - FASTENAL CO (0000815556) (Filer)
Fastenal Co filed a Form 8-K on October 14, 2026, reporting its results of operations and financial condition and providing financial statements and related exhibits.
- 8-K - Entrada Therapeutics, Inc. (0001689375) (Filer)
Entrada Therapeutics, Inc. filed a Form 8-K with the SEC on October 14, 2026, containing a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.
- 8-K - Cipher Digital Inc. (0001819989) (Filer)
Cipher Digital Inc. filed a Form 8-K with the SEC on October 14, 2026, including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - Brightline Interactive, Inc./NV (0001854445) (Filer)
Brightline Interactive, Inc. filed a Form 8-K on October 14, 2026, reporting other events and providing its financial statements and related exhibits.
- 8-K - MORGAN STANLEY (0000895421) (Filer)
Morgan Stanley filed a Form 8-K on October 14, 2026 (Accession No. 0000895421-26-000288) reporting its results of operations and financial condition, and providing its financial statements and related exhibits.
- 8-K - FARADAY FUTURE INTELLIGENT ELECTRIC INC. (0001805521) (Filer)
Faraday Future Intelligent Electric Inc. filed a Form 8-K reporting entry into a material definitive agreement, creation of a direct financial obligation/off-balance-sheet arrangement, unregistered sales of equity securities, a Regulation FD disclosure, and related financial statements and exhibits.
- 8-K - FF EAI Robotics Ecosystem Inc. (0001460702) (Filer)
FF EAI Robotics Ecosystem Inc. filed an 8-K on October 14, 2026, reporting entry into a material definitive agreement, unregistered sales of equity securities, a Regulation FD disclosure, and accompanying financial statements and exhibits.